
| Q3 2026 | Q3 2025 | Change | |||||||||||||||
| (in thousands, except per share amounts, percentages and customer count) | |||||||||||||||||
| Key Business Metrics: | |||||||||||||||||
Platform Annual Run-Rate Revenue (1) | $ | 574,112 | $ | 438,612 | 31 | % | |||||||||||
Customer Count (2) | 868 | 713 | 22 | % | |||||||||||||
| Financial Highlights: | |||||||||||||||||
| Revenue | $ | 143,528 | $ | 109,653 | 31 | % | |||||||||||
| Gross Profit | $ | 57,411 | $ | 43,086 | 33 | % | |||||||||||
Adjusted Gross Profit (3) | $ | 58,152 | $ | 43,471 | 34 | % | |||||||||||
Adjusted Gross Margin (3) | 41 | % | 40 | % | 1 | pt | |||||||||||
Adjusted EBITDA (3) | $ | (3,230) | $ | (8,692) | (63) | % | |||||||||||
Adjusted EBITDA Margin (3) | (2) | % | (8) | % | 6 | pts | |||||||||||
| Net Loss | $ | (18,759) | $ | (36,887) | (49) | % | |||||||||||
Adjusted Net Loss (3) | $ | (350) | $ | (9,260) | (96) | % | |||||||||||
| Net Loss per Share—Basic and Diluted | $ | (0.23) | $ | (1.49) | (85) | % | |||||||||||
Adjusted Net Loss per Share—Basic and Diluted (3) | $ | (0.00) | $ | (0.37) | (100) | % | |||||||||||
| Q4 2026 | FY 2026 | ||||||||||
| ($ in millions) | |||||||||||
| Platform Revenue | $150.0 - $151.7 | $556.7 - $558.4 | |||||||||
| YoY Growth % | 26.1% - 27.6% | 28.2% - 28.6% | |||||||||
Adjusted EBITDA (1) | $0.0 - $1.5 | ($12.5) - ($11.0) | |||||||||
Adjusted EBITDA Margin (1) | 0.0% - 1.0% | (2.2)% - (2.0)% | |||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| ($ in thousands, except share and per share amounts) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Revenue | $ | 143,528 | $ | 109,653 | $ | 406,669 | $ | 315,428 | |||||||||||||||
Cost of revenue (1) | 86,117 | 66,567 | 243,597 | 190,581 | |||||||||||||||||||
| Gross profit | 57,411 | 43,086 | 163,072 | 124,847 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
Research and development (1) | 26,229 | 23,131 | 76,865 | 67,214 | |||||||||||||||||||
Sales and marketing (1) | 20,326 | 17,657 | 61,958 | 48,832 | |||||||||||||||||||
General and administrative (1) | 32,088 | 21,189 | 90,819 | 61,026 | |||||||||||||||||||
| Total operating expenses | 78,643 | 61,977 | 229,642 | 177,072 | |||||||||||||||||||
| Operating loss | (21,232) | (18,891) | (66,570) | (52,225) | |||||||||||||||||||
| Interest income | 2,631 | 883 | 8,209 | 1,937 | |||||||||||||||||||
| Interest expense | (479) | (2,147) | (990) | (6,972) | |||||||||||||||||||
| Loss on extinguishment of convertible notes | — | (10,949) | — | (10,949) | |||||||||||||||||||
| Other income (expense)—net | 232 | (5,293) | 1,520 | (4,082) | |||||||||||||||||||
Loss before income taxes | (18,848) | (36,397) | (57,831) | (72,291) | |||||||||||||||||||
| Provision for (benefit from) income taxes | (89) | 490 | 633 | 2,134 | |||||||||||||||||||
| Net loss | $ | (18,759) | $ | (36,887) | $ | (58,464) | $ | (74,425) | |||||||||||||||
| Basic and diluted net loss per share: | |||||||||||||||||||||||
| Net loss per share—basic and diluted | $ | (0.23) | $ | (1.49) | $ | (0.72) | $ | (4.43) | |||||||||||||||
| Weighted average shares of common stock outstanding used in computing net loss per share—basic and diluted | 81,675,824 | 24,730,353 | 81,398,528 | 16,816,111 | |||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| ($ in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Cost of revenue | $ | 100 | $ | 41 | $ | 273 | $ | 147 | |||||||||||||||
| Research and development | 4,488 | 1,923 | 12,820 | 5,086 | |||||||||||||||||||
| Sales and marketing | 2,395 | 1,906 | 9,346 | 4,445 | |||||||||||||||||||
| General and administrative | 8,380 | 3,633 | 24,498 | 7,178 | |||||||||||||||||||
| Total | $ | 15,363 | $ | 7,503 | $ | 46,937 | $ | 16,856 | |||||||||||||||
| ($ in thousands) | September 30, 2026 | December 31 2025 | |||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 322,803 | $ | 370,914 | |||||||
Accounts receivable—net of allowance of $13 and $24 as of September 30, 2026 and December 31, 2025, respectively | 123,338 | 81,572 | |||||||||
| Prepaid expenses and other current assets | 17,900 | 17,065 | |||||||||
| Total current assets | 464,041 | 469,551 | |||||||||
| Noncurrent assets: | |||||||||||
| Restricted cash and cash equivalents | 1,257 | 1,171 | |||||||||
| Property and equipment—net | 17,757 | 13,395 | |||||||||
| Operating lease right-of-use assets | 24,013 | 18,319 | |||||||||
| Deferred tax assets | 520 | 529 | |||||||||
| Intangible assets—net | 31,631 | 36,025 | |||||||||
| Goodwill | 190,855 | 192,305 | |||||||||
| Other noncurrent assets | 1,577 | 1,800 | |||||||||
| Total noncurrent assets | 267,610 | 263,544 | |||||||||
| Total assets | $ | 731,651 | $ | 733,095 | |||||||
| ($ in thousands) | September 30, 2026 | December 31, 2025 | |||||||||
| Liabilities and stockholders' equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 5,156 | $ | 4,427 | |||||||
| Accrued expenses and other current liabilities | 25,452 | 24,886 | |||||||||
| Operating lease liabilities | 11,796 | 9,749 | |||||||||
| Deferred revenue | 24,384 | 26,893 | |||||||||
| Insurance payables | 14,102 | 15,144 | |||||||||
| Accrued compensation and benefits | 18,278 | 13,136 | |||||||||
| Total current liabilities | 99,168 | 94,235 | |||||||||
| Noncurrent liabilities: | |||||||||||
| Operating lease liabilities | 12,498 | 9,378 | |||||||||
| Deferred revenue | 896 | 1,746 | |||||||||
| Total noncurrent liabilities | 13,394 | 11,124 | |||||||||
| Total liabilities | 112,562 | 105,359 | |||||||||
| Stockholders' equity: | |||||||||||
| Preferred stock | — | — | |||||||||
Class A common stock | 1 | 1 | |||||||||
Class B common stock | — | — | |||||||||
Class C common stock | — | — | |||||||||
| Additional paid-in capital | 1,864,281 | 1,811,349 | |||||||||
| Accumulated other comprehensive income (loss) | 4,587 | 7,702 | |||||||||
| Accumulated deficit | (1,249,780) | (1,191,316) | |||||||||
| Total stockholders’ equity | 619,089 | 627,736 | |||||||||
| Total liabilities and stockholders' equity | $ | 731,651 | $ | 733,095 | |||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| ($ in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Operating activities: | |||||||||||||||||||||||
| Net loss | $ | (18,759) | $ | (36,887) | $ | (58,464) | $ | (74,425) | |||||||||||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | — | ||||||||||||||||||||||
| Depreciation and amortization | 2,433 | 2,133 | 7,212 | 6,476 | |||||||||||||||||||
| Stock-based compensation | 15,331 | 6,592 | 46,905 | 15,945 | |||||||||||||||||||
| Deferred income taxes | (119) | (825) | 9 | (775) | |||||||||||||||||||
| Noncash operating lease expense | 3,535 | 2,359 | 9,636 | 6,432 | |||||||||||||||||||
| Revaluation of warrants liability | — | — | — | (2,273) | |||||||||||||||||||
| Revaluation of convertible notes' embedded derivative feature | — | 5,217 | — | 9,312 | |||||||||||||||||||
| Amortization of convertible notes' discount | — | 1,491 | — | 4,819 | |||||||||||||||||||
| Loss on extinguishment of convertible notes | — | 10,949 | — | 10,949 | |||||||||||||||||||
| Changes in operating assets and liabilities: | |||||||||||||||||||||||
| Accounts receivable | (18,728) | (2,061) | (42,369) | (8,315) | |||||||||||||||||||
| Prepaid expenses and other assets | (753) | (1,305) | (1,194) | (2,584) | |||||||||||||||||||
| Accounts payable | (881) | (1,253) | 759 | 1,567 | |||||||||||||||||||
| Accrued expenses and other current liabilities | 1,472 | 107 | (441) | 2,500 | |||||||||||||||||||
| Operating lease liabilities | (3,636) | (2,367) | (9,489) | (6,541) | |||||||||||||||||||
| Deferred revenue | 1,442 | 2,672 | (3,165) | 87 | |||||||||||||||||||
| Accrued compensation and benefits | 5,356 | 3,148 | 5,268 | 2,846 | |||||||||||||||||||
| Insurance payables | (1,226) | 1,500 | (1,042) | 3,566 | |||||||||||||||||||
| Net cash used in operating activities | (14,533) | (8,530) | (46,375) | (30,414) | |||||||||||||||||||
| Investing activities: | |||||||||||||||||||||||
| Purchase of property and equipment | (618) | (354) | (1,296) | (1,337) | |||||||||||||||||||
| Capitalized internal-use software | (2,138) | (1,104) | (6,145) | (3,222) | |||||||||||||||||||
| Acquisitions—net of cash acquired | — | — | 279 | — | |||||||||||||||||||
| Net cash used in investing activities | (2,756) | (1,458) | (7,162) | (4,559) | |||||||||||||||||||
| Financing activities: | |||||||||||||||||||||||
| Proceeds from issuance of Series E convertible preferred stock upon exercise of warrants | — | — | — | 20,000 | |||||||||||||||||||
| Repayment of line of credit | — | (5,000) | — | (10,000) | |||||||||||||||||||
| Proceeds from issuance of convertible notes | — | — | — | 7,500 | |||||||||||||||||||
| Proceeds from exercise of stock options | 4,336 | 7,898 | 6,027 | 9,952 | |||||||||||||||||||
| Proceeds from initial public offering, net of underwriting discounts and commissions | — | 307,871 | — | 307,871 | |||||||||||||||||||
| Payments of initial public offering costs | — | (1,051) | — | (1,051) | |||||||||||||||||||
| Payment of issuance fees | — | — | — | (322) | |||||||||||||||||||
| Net cash provided by financing activities | 4,336 | 309,718 | 6,027 | 333,950 | |||||||||||||||||||
| Effect of foreign exchange on cash, cash equivalents, and restricted cash and cash equivalents | (203) | 261 | (515) | 1,326 | |||||||||||||||||||
| Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents | (13,156) | 299,991 | (48,025) | 300,303 | |||||||||||||||||||
| Cash, cash equivalents, and restricted cash and cash equivalents—beginning of period | 337,216 | 79,301 | 372,085 | 78,989 | |||||||||||||||||||
| Cash, cash equivalents, and restricted cash and cash equivalents—end of period | $ | 324,060 | $ | 379,292 | $ | 324,060 | $ | 379,292 | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| ($ in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Gross profit | $ | 57,411 | $ | 43,086 | $ | 163,072 | $ | 124,847 | |||||||||||||||
| Gross profit margin | 40% | 39% | 40% | 40% | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | 100 | 41 | 273 | 147 | |||||||||||||||||||
Depreciation and amortization (1) | 641 | 344 | 1,829 | 1,198 | |||||||||||||||||||
| Adjusted Gross Profit | $ | 58,152 | $ | 43,471 | $ | 165,174 | $ | 126,192 | |||||||||||||||
| Adjusted Gross Margin | 41% | 40% | 41% | 40% | |||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| ($ in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Net loss | $ | (18,759) | $ | (36,887) | $ | (58,464) | $ | (74,425) | |||||||||||||||
| Interest Income | (2,631) | (883) | (8,209) | (1,937) | |||||||||||||||||||
| Interest expense | 479 | 2,147 | 990 | 6,972 | |||||||||||||||||||
| Loss on extinguishment of convertible notes | — | 10,949 | — | 10,949 | |||||||||||||||||||
| Provision for (benefit from) income taxes | (89) | 490 | 633 | 2,134 | |||||||||||||||||||
| Other (income) expense, net | (232) | 5,293 | (1,520) | 4,082 | |||||||||||||||||||
Depreciation and amortization (1) | 1,838 | 1,542 | 5,451 | 4,804 | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | 15,363 | 7,503 | 46,937 | 16,856 | |||||||||||||||||||
Litigation costs (2) | 180 | (95) | 380 | 2,598 | |||||||||||||||||||
Transaction costs (3) | 356 | 1,249 | 757 | 1,957 | |||||||||||||||||||
| Other | 265 | — | 565 | — | |||||||||||||||||||
| Adjusted EBITDA | $ | (3,230) | $ | (8,692) | $ | (12,480) | $ | (26,010) | |||||||||||||||
| Net loss margin | (13)% | (34)% | (14)% | (24)% | |||||||||||||||||||
| Adjusted EBITDA Margin | (2)% | (8)% | (3)% | (8)% | |||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| ($ in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| GAAP research and development expense | $ | 26,229 | $ | 23,131 | $ | 76,865 | $ | 67,214 | |||||||||||||||
| Depreciation | (96) | (119) | (313) | (395) | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | (4,488) | (1,923) | (12,820) | (5,086) | |||||||||||||||||||
Transaction costs (1) | $ | — | $ | (189) | $ | — | $ | (189) | |||||||||||||||
| Adjusted Research and Development expense | $ | 21,645 | $ | 20,900 | $ | 63,732 | $ | 61,544 | |||||||||||||||
| GAAP sales and marketing expense | $ | 20,326 | $ | 17,657 | $ | 61,958 | $ | 48,832 | |||||||||||||||
| Stock-based compensation and related employer payroll taxes | (2,395) | (1,906) | (9,346) | (4,445) | |||||||||||||||||||
Transaction costs (1) | — | (309) | (32) | (313) | |||||||||||||||||||
| Other | $ | (1) | $ | — | $ | (276) | $ | — | |||||||||||||||
| Adjusted Sales and Marketing expense | $ | 17,930 | $ | 15,442 | $ | 52,304 | $ | 44,074 | |||||||||||||||
| GAAP general and administrative expense | $ | 32,088 | $ | 21,189 | $ | 90,819 | $ | 61,026 | |||||||||||||||
| Depreciation and amortization | (1,101) | (1,079) | (3,309) | (3,211) | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | (8,380) | (3,633) | (24,498) | (7,178) | |||||||||||||||||||
Litigation costs (2) | (180) | 95 | (380) | (2,598) | |||||||||||||||||||
Transaction costs (1) | (356) | (751) | (725) | (1,455) | |||||||||||||||||||
| Other | $ | (264) | $ | — | $ | (289) | $ | — | |||||||||||||||
| Adjusted General and Administrative expense | $ | 21,807 | $ | 15,821 | $ | 61,618 | $ | 46,584 | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| ($ in thousands, except share and per share amounts) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| GAAP net loss | $ | (18,759) | $ | (36,887) | $ | (58,464) | $ | (74,425) | |||||||||||||||
| Amortization of discount on convertible notes | — | 1,491 | — | 4,819 | |||||||||||||||||||
| Loss on extinguishment of convertible notes | — | 10,949 | — | 10,949 | |||||||||||||||||||
| Revaluation of warrants liability | — | — | — | (2,273) | |||||||||||||||||||
| Revaluation of convertible notes embedded derivative feature | — | 5,217 | — | 9,312 | |||||||||||||||||||
| Employee retention credit | — | (441) | (1,758) | (2,252) | |||||||||||||||||||
Depreciation and amortization (1) | 1,838 | 1,542 | 5,451 | 4,804 | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | 15,363 | 7,503 | 46,937 | 16,856 | |||||||||||||||||||
Litigation costs (2) | 180 | (95) | 380 | 2,598 | |||||||||||||||||||
Transaction costs (3) | 356 | 1,249 | 757 | 1,957 | |||||||||||||||||||
| Other | 265 | — | 565 | — | |||||||||||||||||||
| Provision for income tax benefit of adjustments | 407 | 212 | 1,173 | 586 | |||||||||||||||||||
| Adjusted Net Loss | $ | (350) | $ | (9,260) | $ | (4,959) | $ | (27,069) | |||||||||||||||
| GAAP net loss per share—basic and diluted | $ | (0.23) | $ | (1.49) | $ | (0.72) | $ | (4.43) | |||||||||||||||
| Adjusted Net Loss per share—basic and diluted | $ | (0.00) | $ | (0.37) | $ | (0.06) | $ | (1.61) | |||||||||||||||
| Weighted average shares of common stock outstanding used in computing net loss per share and Adjusted Net Loss per share—basic and diluted | 81,675,824 | 24,730,353 | 81,398,528 | 16,816,111 | |||||||||||||||||||